EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:92386 - xylazine
| Formula | C12H16N2S |
| Net Charge | 0 |
| Average Mass | 220.341 |
| Monoisotopic Mass | 220.10342 |
| SMILES | Cc1cccc(C)c1NC1=NCCCS1 |
| InChI | InChI=1S/C12H16N2S/c1-9-5-3-6-10(2)11(9)14-12-13-7-4-8-15-12/h3,5-6H,4,7-8H2,1-2H3,(H,13,14) |
| InChIKey | BPICBUSOMSTKRF-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. alpha-adrenergic agonist An agent that selectively binds to and activates α-adrenergic receptors. |
| Applications: | sedative A central nervous system depressant used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. emetic Any agent that induces nausea and vomiting. muscle relaxant A drug used to produce muscle relaxation (excepting neuromuscular blocking agents). Its primary clinical and therapeutic use is the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. Also used for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in multiple sclerosis. alpha-adrenergic agonist An agent that selectively binds to and activates α-adrenergic receptors. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| xylazine (CHEBI:92386) has role analgesic (CHEBI:35480) |
| xylazine (CHEBI:92386) has role emetic (CHEBI:149552) |
| xylazine (CHEBI:92386) has role muscle relaxant (CHEBI:51371) |
| xylazine (CHEBI:92386) has role sedative (CHEBI:35717) |
| xylazine (CHEBI:92386) has role α-adrenergic agonist (CHEBI:35569) |
| xylazine (CHEBI:92386) is a 1,3-thiazine (CHEBI:46975) |
| xylazine (CHEBI:92386) is a methylbenzene (CHEBI:38975) |
| xylazine (CHEBI:92386) is a secondary amino compound (CHEBI:50995) |
| xylazine (CHEBI:92386) is conjugate base of xylazine(1+) (CHEBI:149565) |
| Incoming Relation(s) |
| xylazine(1+) (CHEBI:149565) is conjugate acid of xylazine (CHEBI:92386) |
| IUPAC Name |
|---|
| N-(2,6-dimethylphenyl)-5,6-dihydro-4H-1,3-thiazin-2-amine |
| INNs | Source |
|---|---|
| xilazina | WHO MedNet |
| xylazine | WHO MedNet |
| xylazine | WHO MedNet |
| xylazinum | WHO MedNet |
| Synonyms | Source |
|---|---|
| 2-(2,6-dimethylanilino)-5,6-dihydro-4H-1,3-thiazine | ChemIDplus |
| 2-(2,6-dimethylphenylamino)-4H-5,6-dihydro-1,3-thiazine | ChemIDplus |
| 5,6-dihydro-2-(2,6-xylidino)-4H-1,3-thiazine | ChemIDplus |
| BAY 1470 | DrugBank |
| N-(5,6-dihydro-4H-1,3-thiazinyl)-2,6-xylidine | ChemIDplus |
| WH 7286 | DrugBank |
| Brand Names | Source |
|---|---|
| Chanazine | KEGG DRUG |
| Rompun | ChEBI |
| Citations |
|---|